Author:
Theodorou Daphne J.,Theodorou Stavroula J.,Rizos Dimitrios
Reference11 articles.
1. Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: rationale and methodology of the CORONA-VTE-Network study;Bikdeli;Thromb. Res.,2023
2. Registry of arterial and venous thromboembolic complications in patients with COVID-19;Piazza;J. Am. Coll. Cardiol.,2020
3. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices - United States, July 2021;Rosenblum;MMWR Morb. Mortal. Wkly Rep.,2021
4. COVID-19, vaccines, and thrombotic events: a narrative review;Arbignani;J. Clin. Med.,2022
5. Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: reports to the Vaccine Adverse Event Reporting System (VAERS);Woo;Pharmacoepidemiol. Drug Saf.,2022